Wordt geladen...
Therapeutic Potential of Targeting the Ghrelin Pathway
Ghrelin was discovered in 1999 as the endogenous ligand of the growth-hormone secretagogue receptor 1a (GHSR1a). Since then, ghrelin has been found to exert a plethora of physiological effects that go far beyond its initial characterization as a growth hormone (GH) secretagogue. Among the numerous w...
Bewaard in:
| Gepubliceerd in: | Int J Mol Sci |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
MDPI
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5412382/ https://ncbi.nlm.nih.gov/pubmed/28398233 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms18040798 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|